This article in the Arizona Republic explains Dr. Huentelman’s vision for MindCrowd and how scientists are going to use the test results to help find a cure for Alzheimer’s.

Huentelman, a scientific researcher at Phoenix-based Translational Genomics Research Institute, founded MindCrowd— a mass online scientific study aimed at studying memory in relation to genetics. It’s the first of its kind, he says.

Matt Huentelman founded MindCrowd to study how cognition and memory change as people age. The results so far have supported his hypothesis- Test performance decreases with age
Matt Huentelman founded MindCrowd to study how cognition and memory change as people age. The results so far have supported his hypothesis: Test performance decreases with age.

“Before we can discover new treatments for brain-related diseases such as Alzheimer’s and Parkinson’s, we need to understand the human genetic blueprint – DNA – that determines how the brain works in healthy individuals,” he (Huentelman) said. “Then, we will be better equipped to develop new medicines and therapies for individuals with brain disorders.”

Read the article here.


You can make a difference.

MindCrowd is the first online research project of its kind to study millions of individuals to help bring us closer to a cure for Alzheimer’s. Help us reach the 1 million people mark.



Stay tuned for news about brain aging and how you can use them to avoid cognitive decline.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *